Literature DB >> 20025644

Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study.

D Green1, C Chan, J Kang, K Liu, P Schreiner, N S Jenny, R P Tracy.   

Abstract

OBJECTIVE: To examine the strength of the associations of fibrinogen with subclinical atherosclerosis in healthy persons.
METHODS: A population-based, prospective, observational study of black and white men and women (Coronary Artery Risk Development in Young Adults [CARDIA]). Fibrinogen levels were measured at year 7 (ages 25-37, n = 2969), and again at year 20 (ages 38-50, n = 2832). Measures of subclinical atherosclerosis (coronary artery calcification [CAC] and carotid intimal-medial thickness [CIMT]) were recorded at year 20.
RESULTS: Over the 13-year study interval (1992-1993 to 2005-2006), fibrinogen rose from a mean of 3.32 to 4.05 g L(-1). After adjusting for age, gender and race, fibrinogen was positively associated with greater incidence of CAC and increased CIMT cross-sectionally as well as after 13 years of follow-up (all P-trend < 0.001). After further adjustment for field center, BMI, smoking, education, systolic blood pressure, diabetes, antihypertensive medication use, total and HDL cholesterol, and CRP, significant positive relationships between fibrinogen and incidence of CAC remained for the total cohort longitudinally (P-trend = 0.037), but not cross-sectionally (P-trend = 0.147).
CONCLUSION: This 13-year study demonstrates that higher levels of fibrinogen during young adulthood are positively associated with incidence of CAC and increased CIMT in middle-age, but the strength of the association declines with increasing age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025644      PMCID: PMC2856753          DOI: 10.1111/j.1538-7836.2009.03727.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  32 in total

1.  Effects of smoking and abstention from smoking on fibrinogen synthesis in humans.

Authors:  K A Hunter; P J Garlick; I Broom; S E Anderson; M A McNurlan
Journal:  Clin Sci (Lond)       Date:  2001-04       Impact factor: 6.124

2.  The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease.

Authors:  P Y Kim; R J Stewart; S M Lipson; M E Nesheim
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

3.  Mineral surface in calcified plaque is like that of bone: further evidence for regulated mineralization.

Authors:  Melinda J Duer; Tomislav Friscić; Diane Proudfoot; David G Reid; Michael Schoppet; Catherine M Shanahan; Jeremy N Skepper; Erica R Wise
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-08-14       Impact factor: 8.311

4.  Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults.

Authors:  J A Hoff; E V Chomka; A J Krainik; M Daviglus; S Rich; G T Kondos
Journal:  Am J Cardiol       Date:  2001-06-15       Impact factor: 2.778

5.  Association of fibrinogen with quantity of coronary artery calcification measured by electron beam computed tomography.

Authors:  L F Bielak; G G Klee; P F Sheedy; S T Turner; R S Schwartz; P A Peyser
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

6.  Determinants of population changes in fibrinogen and factor VII over 6 years: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; K K Wu; M Rasmussen; L E Chambless; N Aleksic; F J Nieto
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

7.  RR interval variability is inversely related to inflammatory markers: the CARDIA study.

Authors:  Richard P Sloan; Heather McCreath; Kevin J Tracey; Stephen Sidney; Kiang Liu; Teresa Seeman
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

8.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

Authors:  Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

9.  Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study.

Authors:  David Green; Nancy Foiles; Cheeling Chan; Pamela J Schreiner; Kiang Liu
Journal:  Atherosclerosis       Date:  2008-07-03       Impact factor: 5.162

10.  Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease.

Authors:  J W Bartlett; B L De Stavola; T W Meade
Journal:  J Thromb Haemost       Date:  2008-11-22       Impact factor: 5.824

View more
  16 in total

1.  Long-term variability of inflammatory markers and associated factors in a population-based cohort.

Authors:  Scott D Nash; Karen J Cruickshanks; Ronald Klein; Barbara E K Klein; F Javier Nieto; Rick Chappell; Carla R Schubert; Michael Y Tsai
Journal:  J Am Geriatr Soc       Date:  2013-07-26       Impact factor: 5.562

2.  Long-term assessment of systemic inflammation and the cumulative incidence of age-related hearing impairment in the epidemiology of hearing loss study.

Authors:  Scott D Nash; Karen J Cruickshanks; Weihai Zhan; Michael Y Tsai; Ronald Klein; Rick Chappell; F Javier Nieto; Barbara E K Klein; Carla R Schubert; Dayna S Dalton; Theodore S Tweed
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-06-05       Impact factor: 6.053

3.  Gamma prime (γ') fibrinogen and carotid intima-media thickness: the Atherosclerosis Risk in Communities study.

Authors:  Pamela J Schreiner; Duke Appiah; Aaron R Folsom
Journal:  Blood Coagul Fibrinolysis       Date:  2017-12       Impact factor: 1.276

4.  13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Tochi M Okwuosa; Oana Klein; Cheeling Chan; Nancy Swords Jenny; Pamela Schreiner; David Green; Kiang Liu
Journal:  Atherosclerosis       Date:  2012-10-25       Impact factor: 5.162

5.  Association between Fibrinogen and Carotid Atherosclerosis According to Smoking Status in a Korean Male Population.

Authors:  Hye Min Cho; Dae Ryong Kang; Hyeon Chang Kim; Sun Min Oh; Byeong-Keuk Kim; Il Suh
Journal:  Yonsei Med J       Date:  2015-07       Impact factor: 2.759

6.  Higher fibrinogen level is independently linked with the presence and severity of new-onset coronary atherosclerosis among Han Chinese population.

Authors:  Yan Zhang; Cheng-Gang Zhu; Yuan-Lin Guo; Rui-Xia Xu; Sha Li; Qian Dong; Jian-Jun Li
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

7.  Sex difference in clot lysability and association to coronary artery calcification.

Authors:  Ramshanker Ramanathan; Niels Peter R Sand; Johannes J Sidelmann; Bjarne L Nørgaard; Jørgen B Gram
Journal:  Biol Sex Differ       Date:  2018-02-13       Impact factor: 5.027

8.  Association of fibrinogen with severity of stable coronary artery disease in patients with type 2 diabetic mellitus.

Authors:  Li-Feng Hong; Xiao-Lin Li; Song-Hui Luo; Yuan-Lin Guo; Cheng-Gang Zhu; Ping Qing; Na-Qiong Wu; Jian-Jun Li
Journal:  Dis Markers       Date:  2014-04-06       Impact factor: 3.434

9.  Relation between admission plasma fibrinogen levels and mortality in Chinese patients with coronary artery disease.

Authors:  Yong Peng; Hua Wang; Yi-Ming Li; Bao-Tao Huang; Fang-Yang Huang; Tian-Li Xia; Hua Chai; Peng-Ju Wang; Wei Liu; Chen Zhang; Mao Chen; De-Jia Huang
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

10.  Association between fibrinogen level and the severity of coronary stenosis in 418 male patients with myocardial infarction younger than 35 years old.

Authors:  Xiong-Yi Gao; Bing-Yang Zhou; Min-Zhou Zhang; Xi Zhao; Ping Qing; Cheng-Gang Zhu; Na-Qiong Wu; Yuan-Lin Guo; Ying Gao; Xiao-Lin Li; Yao Wang; Geng Liu; Qian Dong; Li-Heng Guo; Jian-Jun Li
Journal:  Oncotarget       Date:  2017-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.